The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHaydale Regulatory News (HAYD)

Share Price Information for Haydale (HAYD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.46
Bid: 0.45
Ask: 0.47
Change: 0.00 (0.00%)
Spread: 0.02 (4.444%)
Open: 0.46
High: 0.46
Low: 0.46
Prev. Close: 0.46
HAYD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director Dealing

1 Dec 2015 12:05

RNS Number : 5744H
Haydale Graphene Industries PLC
01 December 2015
 

Haydale Graphene Industries plc

("Haydale" or the "Company")

 

Director Dealing

 

 

Haydale (AIM: HAYD), the group focused on the commercialisation of graphene and other nano particle products using its proprietary plasma process, announces that, on 1 December 2015, Ray Gibbs, Chief Executive, made the following transactions:

 

1. Exercise of 40,500 options under the 2013 Share Option Scheme to subscribe for a total of 40,500 ordinary shares of 2 pence each in the Company ("Ordinary Shares") at an exercise price of 92.5926 pence per share; and

 

2. Sale of 40,500 Ordinary Shares, at a price of 170.5 pence per share.

 

The sale proceeds will be used to fund, in part, the subscription of new shares by Ray Gibbs as outlined in the announcement on 2 November 2015.

 

Following the exercise of these options and disposal of shares, Mr. Gibbs' interest in the Company will remain unchanged at 469,929 Ordinary Shares representing 3.08% of the issued share capital of the Company.

 

Application has been made for the 40,500 Ordinary Shares to be admitted to trading on AIM and trading of these shares is expected to commence on or around 2 December 2015 ("Admission").

 

Following Admission, the Company has 15,236,946 Ordinary Shares in issue. The figure of 15,236,946 Ordinary Shares may be used by shareholders of Haydale as the denominator for the calculations to determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

 

 

- Ends -

 

 

For further information, please contact:

 

Haydale Graphene Industries plc

+44 (0) 1269 842 946

John Knowles, Chairman

Ray Gibbs, Chief Executive Officer

 

Cairn Financial Advisers LLP (Nomad)

+44 (0) 20 7148 7900

Tony Rawlinson

Emma Earl

 

Cantor Fitzgerald Europe (Broker)

+44 (0) 20 7894 7000

David Foreman, Will Goode (Corporate Finance)

David Banks, Tessa Sillars (Corporate Broking)

 

Hermes Financial PR

Trevor Phillips

Chris Steele

+44 (0) 7889 153 628

+44 (0) 7979 604 687

 

 

About Haydale (www.haydale.com)

Haydale has developed a patent pending proprietary scalable plasma process to functionalise graphene and other nanomaterials. This enabling technology can provide Haydale with a rapid and highly cost efficient method of supplying tailored solutions to enhance applications for both raw material suppliers and product manufacturers.

Functionalisation is carried out through a low pressure plasma process that treats both organic mined fine powder and other synthetically produced nanomaterial powders producing high quality few layered graphenes and graphene nano platelets. The process can functionalise with a range of chemical groups, where the amount of chemicals can be tailored to the customer needs. Good dispersion improves the properties and performance of the host material and ensures it delivers as specified.

The Haydale plasma process does not use wet chemistry, neither does it damage the material being processed, rather it can clean up impurities inherent in the raw material. The technology is a low energy user and most importantly environmentally friendly. The Haydale method is an enabling technology where working with a raw material producer can add value to the base product and tailor the outputs to meet the target applications of the end user.

Haydale, based in South Wales, housed in a purpose built facility for processing and handling nanomaterials with a laboratory facility, is facilitating the application of graphenes and other nanomaterials in fields such as inks, sensors, energy storage, photovoltaics, composites, paints and coatings.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSBDBDDSGGBGUB
Date   Source Headline
13th Jun 20189:00 amRNSPrice Monitoring Extension
13th Jun 20187:00 amRNSTrading Statement and Director Resignation
25th May 20187:00 amRNSHaydale Ceramics Technologies
16th Apr 20189:10 amRNSNotification of Major Holdings
1st Mar 20187:00 amRNSInterim Results
19th Feb 20187:00 amRNSSupply Agreement with Graphene Platform Corp
25th Jan 20187:00 amRNSTrading Update
18th Jan 20187:00 amRNSChange of Adviser
17th Jan 20187:00 amRNSCommercial Agreement with Talga Resources
18th Dec 20177:00 amRNSShare options and awards, LTIP and PDMR dealings
12th Dec 201711:25 amRNSResult of AGM
20th Nov 20177:00 amRNSNew Patent Application
20th Nov 20177:00 amRNSAnnual Report & Notice of AGM
1st Nov 20177:00 amRNSPDMR Dealings
31st Oct 20175:48 pmRNSNotification of Major Holdings
30th Oct 20177:00 amRNSGrant of US Patent
27th Oct 201710:45 amRNSResult of General Meeting, Issue of Equity and TVR
26th Oct 201710:06 amRNSResult of Conditional Offer
19th Oct 20171:20 pmRNSCREST Clarification
10th Oct 20174:21 pmRNSClose of Accelerated Bookbuild
10th Oct 20177:00 amRNSProposed Accelerated Bookbuild to raise £6 million
10th Oct 20177:00 amRNSFull Year Results
26th Sep 20177:00 amRNSEverpower places initial orders for Chinese market
11th Sep 20177:00 amRNSChange of Adviser
1st Sep 20177:00 amRNSNew Sales Contract
22nd Aug 20177:00 amRNSAdvanced Composites Proposed Collaboration
9th Aug 20177:00 amRNSLaunch of Taiwan operations
19th Jul 20177:00 amRNSTrading update
13th Jul 20177:00 amRNSAppointment of Chairman
29th Jun 20177:00 amRNSGrant of Options
20th Jun 20177:00 amRNSIssue of Equity and Total Voting Rights
24th May 201711:30 amRNSPDMR Dealing
15th May 20177:00 amRNSAcquisition of HTI Minority Interest
11th May 20177:00 amRNSMemorandum of Understanding with Nanospan India
9th May 20177:00 amRNSIssue of Equity and Total Voting Rights
28th Apr 20177:00 amRNSIssue of Shares
25th Apr 20177:00 amRNSPDMR Dealing
19th Apr 20177:00 amRNSPDMR Dealing
10th Apr 20177:00 amRNSIssue of Equity and Total Voting Rights
10th Apr 20177:00 amRNSIssue of Shares
31st Mar 20174:00 pmRNSIssue of Equity and Total Voting Rights
31st Mar 20177:00 amRNSIssue of Shares
27th Mar 20175:05 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
22nd Mar 20177:00 amRNSInterim Results
15th Mar 20177:00 amRNSFour-year supply agreement
7th Mar 20177:00 amRNSIssue of Shares
20th Feb 20177:00 amRNSIssue of Shares
3rd Feb 20177:01 amRNSProposed Strategic Investment
3rd Feb 20177:00 amRNSTrading update & Notice of results
16th Jan 201711:45 amRNSDirector Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.